Keywords: Plasmodium vivax; CRPv; Treatment failure; Shawa Robit; Chloroquine; Efficacy; Ethiopia;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Animal papillomavirus models; Innate immune responses to PV infections; BPV; CRPV; CPV; MmuPV1; Vaccine and immunotherapeutics for PV infections; in vivo PV viral function; Codon-modified viral genes;
Short CommunicationAnalysis of virus susceptibility in the invasive insect pest Drosophila suzukii
Keywords: Drosophila suzukii; Virus; Pastrel; DCV; CrPV; FHV;
HPV-transgenic mouse models: Tools for studying the cancer-associated immune response
Keywords: AP-1; activator protein-1; BPV; bovine papillomavirus; CCL; C-C motif ligand chemokine; CD; cluster of differentiation; CIN; cervical intraepithelial neoplasia; COX; cyclooxygenase; CpG; cytosine-phosphate-guanine motif; CPV; canine papillomavirus; CRPV;
Traitement médicamenteux chez la femme transplantée avec un projet de grossesse : Ã propos de deux cas de transplantation pulmonaire et cardio-pulmonaire
Keywords: grossesse; transplantation pulmonaire; médicaments; immunosuppresseurs; tératogénicité; pregnancy; lung transplantation; drugs; immunosuppressants; teratogenicity; 6-TGN; 6 thioguanine nucléotide; ARAII; antagoniste des récepteurs de l'angiotensin
Impact de la mise en place d'un réseau régional de pharmacovigilance sur la notification d'effets indésirables : bilan à 3 ans
Keywords: réseau de pharmacovigilance; audio-visioconférence; notification spontanée; information sur la sécurité des médicaments; pharmacovigilance; audio-videoconference; adverse drug reaction; spontaneous reporting; drug safety; AMM; autorisation de mise s
Le Centre de référence sur les agents tératogènes (CRAT) : une structure pionnière
Keywords: médicament; grossesse; allaitement; malformation; nouveau-né; drug; pregnancy; lactation; birth defect; newborn; ABM; Agence de biomédecine; Afssaps; Agence française de sécurité sanitaire des produits de santé; AMM; autorisation de mise sur le mar
Chocs anaphylactiques d'origine médicamenteuse : sous-notification et PMSI
Keywords: choc anaphylactique; sous-notification; PMSI; pharmacovigilance; anaphylactic shocks; under-reporting; diagnosis related group; pharmacovigilance; BNPV; banque nationale de pharmacovigilance; CA; chocs anaphylactiques ou anaphylatoïdes; CHU; centre hospi
Long-peptide therapeutic vaccination against CRPV-induced papillomas in HLA-A2.1 transgenic rabbits
Keywords: Long peptide; Therapeutic vaccine; CRPV; HLA-A2.1; Transgenic rabbit; T-cell mediated immune response
Isotrétinoïne et grossesse : bilan français de 25 années de suivi
Keywords: isotrétinoïne; grossesse; isotretinoïn; pregnancy; Afssaps; Agence française de sécurité sanitaire des produits de santé; AMM; autorisation de mise sur le marché; ANSM; Agence nationale de sécurité du médicament et des produits de santé; CRAT;
A recombinant cottontail rabbit papillomavirus genome for ectopic expression of genes in cells infected with virus in vivo
Keywords: CRPV; Rabbit; Recombinant tumor virus;
5â²-Untranslated region of heat shock protein 70 mRNA drives translation under hypertonic conditions
Keywords: CrPV; Cricket paralysis virus; FBS; fetal bovine serum; FLuc; Photinus pyralis luciferase; HSPs; heat shock proteins; HSP70; heat shock protein 70; IRES; internal ribosome entry site; RLuc; Renilla reniformis luciferase; SNAT-2; sodium-dependent neutral a
Translation initiation is driven by different mechanisms on the HIV-1 and HIV-2 genomic RNAs
Keywords: 4E-BP; eIF4E-binding protein; BMH; branched multiple hairpins; CrPV; cricket paralysis virus; CSFV; Classical Swine Fever Virus; DIS; dimerization site; eIF; eukaryotic initiation factor; EMCV; encephalomyocarditis virus; FMDV; foot-and-mouth-disease viru
Prescriptions hors-AMM : comment en pratique les identifier, les encadrer, informer et les suivre ?
Keywords: AMM; hors-AMM; AMM conditionnelle; protocole thérapeutique temporaire; réglementation; recommandations temporaires d'utilisation; AMM; autorisation de mise sur le marché; ANSM; Agence nationale de sécurité du médicament et des produits de santé;
Synonymous codon changes in the oncogenes of the cottontail rabbit papillomavirus lead to increased oncogenicity and immunogenicity of the virus
Keywords: Papillomavirus; Synonymous codons; Cancer; Immunogenicity; In vivo model; Codon usage; CRPV; E6; E7
Peut-on améliorer la notification des effets indésirables dans les établissements hospitaliers ? Bilan de 5 ans d'activité du réseau PharmacoMIP
Keywords: pharmacovigilance; assistant recherche clinique; effet indésirable; notification spontanée; pharmacovigilance; clinical research assistant; adverse; drug reactions; spontaneous report; AMM; autorisation de mise sur le marché; ARC; attaché de recherche
Pharmacie clinique et pharmacovigilance à l'hôpital : bilan et perspectives après 9 ans d'expérience
Keywords: pharmacovigilance; pharmacie clinique; pharmacien; pharmacologue; déclaration d'un effet indésirable; pharmacovigilance; clinical pharmacy; pharmacist; pharmacologist; adverse drug reaction report; Afssaps; Agence française de sécurité sanitaire de
Reversal of papilloma growth in rabbits therapeutically vaccinated against E6 with naked DNA and/or vesicular stomatitis virus vectors
Keywords: Human papillomavirus; CRPV; E6; Vaccine; Therapeutic vaccine; Vesicular stomatitis virus vector; DNA vector; Prime-boost; Antitumor immunity; Tumor growth
Mucosally delivered peptides prime strong immunity in HLA-A2.1 transgenic rabbits
Keywords: Peptide delivery; Immunization; CRPV; HHD mice; HLA-A2.1 transgenic rabbits; DNA vaccine; Mucosal delivery; Adjuvant; TT helper; CpG motif; PADRE; Immunogenicity; CTL;
Papillomavirus DNA complementation in vivo
Keywords: CRPV; Dysfunctional genomes; In vivo; DNA recombination; DNA complementation; Rabbits; DNA infection
Wounding prior to challenge substantially improves infectivity of cottontail rabbit papillomavirus and allows for standardization of infection
Keywords: Wounding; Infectivity; Challenge; CRPV; Viral DNA
Sécurité d'emploi des médicaments : évaluation clinique
Keywords: Pharmacovigilance; Gestion de risque; Médicament; Effet indésirable; Pharmacovigilance; Risk management; Drug; Adverse effect; Afssaps; Agence française de sécurité sanitaire des produits de santé; faisant suite à l'Agence du médicament; ancienn
Rabbits immunised with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L2E7E2 genes induces regression of established papillomas
Keywords: CRPV; rBCG; Therapeutic vaccine
Impact of genetic changes to the CRPV genome and their application to the study of pathogenesis in vivo
Keywords: CRPV; Modification; Mutants; DNA challenge; Functional study
Protection of rabbits against cutaneous papillomavirus infection using recombinant tobacco mosaic virus containing L2 capsid epitopes
Keywords: CRPV; TMV; L2; Vaccination; Recombinant virus; Rabbit; Protection; Papilloma
The papillomavirus life cycle
Keywords: HPV; human papillomavirus; BPV; bovine papillomavirus; COPV; canine oral papillomavirus; CRPV; cottontail rabbit papillomavirus; PML; promyelocytic leukaemia; NMSC; non-melanoma skin cancer; Human papillomavirus; Productive infection; Latency; Warts; Papi
Heterologous papillomavirus virus-like particles and human papillomavirus virus-like particle immune complexes activate human Langerhans cells
Keywords: HPV; human papillomavirus; BPV; bovine papillomavirus; CRPV; cotton-tail rabbit papillomavirus; cVLP; chimeric virus-like particle; DC; dendritic cell; LC; Langerhans cell; APC; antigen-presenting cell; IC; immune complex; MHC; major histocompatibility co